antiviral therapy

CAMBRIDGE, UK, Sept. 1, 2026 AstraZeneca and Daiichi Sankyo announced that the European Commission has approved Enhertu (trastuzumab deruxtecan)...

SAN FRANCISCO, California, Sept. 2, 2026 Enliven Therapeutics announced plans to present new clinical and preclinical data from its...

BRUSSELS, Belgium and ATLANTA, Georgia, Aug. 31, 2026 UCB has reached an agreement with the U.S. government aimed at...

BOSTON, Aug. 31, 2026 TransCode Therapeutics announced the publication of new peer-reviewed research reporting a survival benefit for TTX-MC138...

Raleigh, North Carolina, August 31, 2026 RedHill Biopharma Ltd. announced an update on the emergency development of opaganib as...

Miami, Florida, August 12, 2026 Summit Therapeutics announced that its partner Akeso Inc. received marketing authorization from China’s National...

Shanghai, China, August 12, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that China’s National Medical Products Administration (NMPA)...

SOUTH SAN FRANCISCO, Calif., August 12, 2026 Aligos Therapeutics, Inc. announced that its partner Xiamen Amoytop Biotech Co., Ltd....

Minneapolis, Minnesota, August,11, 2026 FastWave Medical has received U.S. Food and Drug Administration (FDA) approval of its Investigational Device...

Kirkland, Washington, August,11, 2026 EIT Pharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...